Drug recall · August 27, 2014
DOBUTamine Injection recall
Why: Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira Inc., Lake Forest, IL 60045 USA. NDC 0409-2344-02
- Lots / codes
Lot # 27-352-DK; Exp 03/15
- Quantity
- 123,900 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- January 10, 2014 · Voluntary: Firm initiated
- Classified
- August 18, 2014
- Reported
- August 27, 2014
- Ended
- July 14, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dobutamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.